{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T14:12:28Z","timestamp":1772806348340,"version":"3.50.1"},"reference-count":37,"publisher":"MDPI AG","issue":"21","license":[{"start":{"date-parts":[[2021,10,24]],"date-time":"2021-10-24T00:00:00Z","timestamp":1635033600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI14\/01199"],"award-info":[{"award-number":["PI14\/01199"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJERPH"],"abstract":"<jats:p>Studies about the survival of patients with prostate cancer by stage or risk of progression are scarce. The aims of this study were (1) to determine the cause-specific survival by risk in prostate cancer patients in Mallorca diagnosed in the period 2006\u20132011; (2) to identify the factors that explain and predict the likelihood of survival and the risk of dying from this type of cancer; and (3) to determine the distribution of prostate cancer by risk in the patients in Mallorca diagnosed in the period 2006\u20132011. Incident prostate cancer cases diagnosed between 2006 and 2011 were identified through the Mallorca Cancer Registry. We collected age; date and method of diagnosis; date of follow-up or death; T, N, M and stage according to the TNM 7th edition; Gleason score; prostate-specific antigen (PSA); histology according to the International Classification of Diseases for Oncology (ICD-O) 3rd edition, comorbidities and treatments. We calculated risk in four categories: low, medium, high and very high. The end point of follow-up was 31 December 2014. Multiple imputation (MI) was performed to estimate cases with unknown risk. We identified 2921 cases. Five years after diagnosis, survival after MI was 89% globally, and was 100% for low-risk cases, 96% for medium risk, 93% for high risk and 69% for very-high-risk cases. Cases with histology other than adenocarcinoma, with high (and especially very high) risk, as well as with systemic, mixed and observation\/unspecified treatments had worse prognoses.<\/jats:p>","DOI":"10.3390\/ijerph182111156","type":"journal-article","created":{"date-parts":[[2021,10,24]],"date-time":"2021-10-24T22:06:16Z","timestamp":1635113176000},"page":"11156","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prostate Cancer Survival by Risk and Other Prognostic Factors in Mallorca, Spain"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1116-1964","authenticated-orcid":false,"given":"Juan Jos\u00e9","family":"Monta\u00f1o","sequence":"first","affiliation":[{"name":"Department of Psychology, University of Balearic Islands (UIB), 07122 Palma, Spain"},{"name":"Health Research Institute of the Balearic Islands (IdISBa), 07120 Palma, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoni","family":"Barcel\u00f3","sequence":"additional","affiliation":[{"name":"Mallorca Cancer Registry, Balearic Islands Public Health Department, 07010 Palma, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"Franch","sequence":"additional","affiliation":[{"name":"Health Research Institute of the Balearic Islands (IdISBa), 07120 Palma, Spain"},{"name":"Mallorca Cancer Registry, Balearic Islands Public Health Department, 07010 Palma, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaume","family":"Galceran","sequence":"additional","affiliation":[{"name":"Tarragona Cancer Registry, Cancer Epidemiology and Prevention Service, Hospital Universitari Sant Joan de Reus, Institut d\u2019Investigaci\u00f3 Sanit\u00e0ria Pere Virgili (IISPV), 43204 Reus, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Ameijide","sequence":"additional","affiliation":[{"name":"Tarragona Cancer Registry, Cancer Epidemiology and Prevention Service, Hospital Universitari Sant Joan de Reus, Institut d\u2019Investigaci\u00f3 Sanit\u00e0ria Pere Virgili (IISPV), 43204 Reus, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaime","family":"Pons","sequence":"additional","affiliation":[{"name":"Mallorca Cancer Registry, Balearic Islands Public Health Department, 07010 Palma, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Ramos","sequence":"additional","affiliation":[{"name":"Health Research Institute of the Balearic Islands (IdISBa), 07120 Palma, Spain"},{"name":"Mallorca Cancer Registry, Balearic Islands Public Health Department, 07010 Palma, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,10,24]]},"reference":[{"key":"ref_1","unstructured":"Cancer Today (2019, October 10). Global Cancer Observatory. Available online: http:\/\/gco.iarc.fr\/today\/home."},{"key":"ref_2","unstructured":"(2021, January 03). Estimaciones de la incidencia del c\u00e1ncer en Espa\u00f1a, 2020. Available online: https:\/\/redecan.org\/redecan.org\/es\/estimaciones-incidencia2020.html?id=196&title=estimaciones-de-la-incidencia-del-c%C3%A1ncer-en-Espa%C3%B1a-2020."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1016\/j.ejca.2015.07.027","article-title":"Survival of male genital cancers (prostate, testis and penis) in Europe 1999\u20132007: Results from the EUROCARE-5 study","volume":"51","author":"Trama","year":"2015","journal-title":"Eur J. Cancer"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1007\/s12094-012-0824-0","article-title":"Trends in prostate cancer-survival in Spain: Results from population-based cancer registries","volume":"14","author":"Izarzugaza","year":"2012","journal-title":"Clin. Transl Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/S0140-6736(14)62038-9","article-title":"Global surveillance of cancer survival 1995\u20132009: Analysis of individual data for 25,676 887 patients from 279 population-based registries in 67 countries (CONCORD-2)","volume":"385","author":"Allemani","year":"2015","journal-title":"Lancet"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Sobin, L.H., Gospodarowicz, M.K., and Wittekind, C. (2011). TNM Classification of Malignant Tumours, Wiley-Blackwell. [7th ed.].","DOI":"10.1002\/9780471420194.tnmc26"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"121","DOI":"10.5489\/cuaj.11085","article-title":"Pre-treatment risk stratification of prostate cancer patients: A critical review","volume":"6","author":"Rodrigues","year":"2012","journal-title":"Can. Urol Assoc. J."},{"key":"ref_8","unstructured":"Mottet, N., Cornford, P., van den Bergh, R.C.N., Briers, E., De Santis, M., Fanti, S., Gillessen, S., Grummet, J., Henry, A.M., and Lam, T.B. (2021, March 08). Prostate Cancer. Available online: https:\/\/uroweb.org\/guideline\/prostate-cancer\/#6_6."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1177\/2051415816673502","article-title":"Novel concepts for risk stratification in prostate cancer","volume":"9","author":"Patel","year":"2017","journal-title":"J. Clin. Urol."},{"key":"ref_10","unstructured":"Klein, E.A. (2019, October 15). Prostate Cancer: Risk Stratification and Choice of Initial Treatment. Available online: https:\/\/www.uptodate.com\/contents\/prostate-cancer-risk-stratification-and-choice-of-initial-treatment."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.critrevonc.2005.08.003","article-title":"Impact of comorbidity on treatment and prognosis of prostate cancer patients: A population-based study","volume":"58","author":"Houterman","year":"2006","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1159\/000477096","article-title":"Primary treatment choice over time and relative survival of prostate cancer patients: Influence of age, grade and stage","volume":"40","author":"Matthes","year":"2017","journal-title":"Oncol. Res. Treat."},{"key":"ref_13","unstructured":"Frita, A.P.C., Jack, A., Shanmugaratnam, K., Sobin, L., Parkin, D.M., and Whelan, S. (2013). International Classification of Diseases for Oncology (ICD-O), 1st rev., World Health Organization. [3rd ed.]. Available online: https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/96612\/9789241548496%20eng.pdf;jsessionid=7B2E052FBC84832B13B32AC8B483E069?sequence=1."},{"key":"ref_14","unstructured":"Statistics (2019, October 15). Populations. Deaths. Institut Balear d\u2019Estad\u00edstica., Available online: https:\/\/ibestat.caib.es\/ibestat\/estadistiques\/poblacio\/defuncions\/c15a61f7-b12e-42d7-abed-bb6f03343656."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/sim.4067","article-title":"Multiple imputation using chained equations: Issues and guidance for practice","volume":"30","author":"White","year":"2011","journal-title":"Stat. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.canep.2016.01.001","article-title":"Colorectal cancer survival by stage of cases diagnosed in Mallorca, Spain, between 2006 and 2011 and factors associated with survival","volume":"41","author":"Ramos","year":"2016","journal-title":"Cancer Epidemiol."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Rubin, D.B. (1987). Multiple Imputation for Nonresponse in Surveys, John Wiley & Sons.","DOI":"10.1002\/9780470316696"},{"key":"ref_18","unstructured":"Pearson, K. (1904). On the Theory of Contingency and Its Relation to Association and Normal Correlation, Dulau and CO."},{"key":"ref_19","unstructured":"Cramer, H. (1946). Mathematical Models of Statistics, Princeton University Press."},{"key":"ref_20","first-page":"101","article-title":"The relative survival: A statistical methodology","volume":"6","author":"Ederer","year":"1961","journal-title":"Natl. Cancer Inst. Monog."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J. Am. Stat. Ass."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life-tables","volume":"34","author":"Cox","year":"1972","journal-title":"J. R. Stat. Soc. Series. B"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0140-6736(17)33326-3","article-title":"Global surveillance of trends in cancer survival 2000\u201314 (CONCORD-3): Analysis of individual records for 37\u2008513\u2008025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries","volume":"391","author":"Allemani","year":"2018","journal-title":"Lancet"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1158\/1055-9965.EPI-19-0125","article-title":"Differences in cancer survival with relative versus cause-specific approaches: An update using major accurate life tables","volume":"28","author":"Howlader","year":"2019","journal-title":"Cancer Epidemiol. Biomakers Prev."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"4773","DOI":"10.1002\/cam4.1706","article-title":"A comparison of relative survival and cause-specific survival methods to measure net survival in cancer populations","volume":"7","author":"Makkar","year":"2018","journal-title":"Cancer Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/ijc.28645","article-title":"A comparison of relative and cause-specific survival by cancer site, age and time since diagnosis","volume":"135","author":"Skyrud","year":"2014","journal-title":"Int. J. Cancer"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.canep.2018.11.003","article-title":"Imputation of missing prostate cancer stage in English cancer registry data based on clinical assumptions","volume":"58","author":"Parry","year":"2019","journal-title":"Cancer Epidemiol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1245\/s10434-018-07128-3","article-title":"Lessons learned regarding missing clinicalstage in the national cancer database","volume":"26","author":"Hoskin","year":"2019","journal-title":"Ann. Surg. Oncol."},{"key":"ref_29","first-page":"1","article-title":"Lung cancer survival by stage of cases diagnosed in Mallorca, Spain, between 2006 and 2011 and factors associated with survival","volume":"3","author":"Ramos","year":"2017","journal-title":"Pulm. Med. Respir. Res."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Eisemann, N., Waldmann, A., and Katalinic, A. (2011). Imputation of missing values of tumour stage in population-based cancer registration. BMC Med. Res. Methodol., 11.","DOI":"10.1186\/1471-2288-11-129"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0895-4356(02)00539-5","article-title":"Developing a prognostic model in the presence of missing data: An ovarian cancer case study","volume":"56","author":"Clark","year":"2003","journal-title":"J. Clin. Epidemiol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/nrclinonc.2014.68","article-title":"\u201cHigh-Risk\u201d Prostate Cancer: Classification and Therapy","volume":"11","author":"Chang","year":"2014","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_33","first-page":"203","article-title":"High-risk prostate cancer. Optimal treatment. New evidences","volume":"72","year":"2019","journal-title":"Arch. Esp. Urol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s00432-018-2596-6","article-title":"Impact of comorbidities at diagnosis on prostate cancer treatment and survival","volume":"144","author":"Matthes","year":"2018","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1200\/JCO.2010.31.2330","article-title":"Impact of comorbidity on survival among men with localized prostate cancer","volume":"29","author":"Albertsen","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"ref_36","first-page":"616","article-title":"Adherence to cancer treatment guidelines: Influence of general and cancer-specific guideline characteristics","volume":"27","author":"Heins","year":"2016","journal-title":"Eur. J. Public Health"},{"key":"ref_37","first-page":"309","article-title":"Tratamiento del c\u00e1ncer de pr\u00f3stata en funci\u00f3n de la esperanza de vida, la comorbilidad y las gu\u00edas de pr\u00e1ctica cl\u00ednica","volume":"37","author":"Ramos","year":"2014","journal-title":"Sist. Sanit. Navar."}],"container-title":["International Journal of Environmental Research and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1660-4601\/18\/21\/11156\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:22:13Z","timestamp":1760167333000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1660-4601\/18\/21\/11156"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,24]]},"references-count":37,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2021,11]]}},"alternative-id":["ijerph182111156"],"URL":"https:\/\/doi.org\/10.3390\/ijerph182111156","relation":{},"ISSN":["1660-4601"],"issn-type":[{"value":"1660-4601","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,24]]}}}